2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1

Molecular and Cellular Biochemistry

Volumn 352, Issue 1-2, 2011, Pages 221-230

  Gong, Qian Fen ^a   Liu, E Hu ^a   Xin, Rong ^a   Huang, Xiuning ^a   Gao, Ning ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

2 Hydroxyestradiol; 2 Methoxyestradiol; Chk1; G2 M arrest; p53

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; 4 HYDROXYESTRADIOL; 4 METHOXYESTRADIOL; CELL CYCLE PROTEIN 20; CHECKPOINT KINASE 1; CYCLIN B1; ESTRADIOL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN RL 95 2; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME INDUCTION; FLUORESCENCE ACTIVATED CELL SORTING; GENE INACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; G2 PHASE; HUMANS; PROTEIN KINASES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959214101     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0757-x     Document Type: Article

References (29)

1. American Cancer Society (2009) Cancer facts and figures. American Cancer Society, Atlanta, p 2009
2. Zhu BT, Lee AJ (2005) NADPH-dependent metabolism of 17β-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. Steroids 70:225-244 (Pubitemid 40387377)
3. Martucci CP, Fishman J (1993) P450 enzymes of estrogen metabolism. Pharmacol Ther 57:237-257 (Pubitemid 23175382)
4. Tsuchiya Y, Nakajima M, Yokoi T (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227:115-124 (Pubitemid 41174580)
5. Parl FF, Egan KM, Li C, Crooke PS (2009) Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform 7:109-121
6. Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG, Guttenplan JB (2006) Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat embryonic cells, and the mutational spectrum of 4-hydroxy-estradiol. Chem Res Toxicol 19:475-479
7. Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA, Roos BA (2001) 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285:1259-1266 (Pubitemid 32912919)
8. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375 (Pubitemid 38340305)
9. Gupta M, McDougal A, Safe S (1998) Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 67:413-419 (Pubitemid 29049414)
10. Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9:749-758
11. Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137:413-431
12. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815 (Pubitemid 32458690)
13. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al (1999) GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 96:3706-3711 (Pubitemid 29168974)
14. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mossner J (2000) The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 28:4410-4418
15. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev 14:1448-1459 (Pubitemid 30421838)
16. Furnari B, Rhind N, Russell P (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277:1495-1497 (Pubitemid 27449235)
17. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14:289-300 (Pubitemid 30106484)
18. Tian H, Faje AT, Lee SL, Jorgensen TJ (2002) Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways. Neoplasia 4:171-180 (Pubitemid 34218685)
19. Kato S, Sadarangani A, Lange S, Villalon M, Branes J, Brosens JJ, Owen GI, Cuello M (2007) The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. Endocr Relat Cancer 14:351-368 (Pubitemid 47242635)
20. Gao N, Budhraja A, Cheng S, Yao H, Zhang Z, Shi X (2009) Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res 15:140-149
21. Carter J, Pather S (2006) An overview of uterine cancer and its management. Exp Rev Anticancer Ther 6:33-42
22. Schutze N, Vollmer G, Tiemann I, Geiger M, Knuppen R (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists. J Steroid Biochem Mol Biol 46:781-789
23. Seeger H, Wallwiener D, Kraemer E, Mueck AO (2006) Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 54:72-77
24. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239 (Pubitemid 24108838)
25. Ball P, Knuppen R (1980) Catecholoestrogens (2- and 4-hydroxyestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh) 232:1-127
26. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
27. Boulaire J, Fotedar A, Fotedar R (2000) The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol Biol (Paris) 48:190-202 (Pubitemid 30318121)
28. Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace AJ Jr (1999) Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18:2892-2900 (Pubitemid 29250879)
29. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196